Trial intelligence / Profile preview

Efficacy of Sulfadoxine-Pyrimethamine in HIV-Infected and Uninfected Adults with Malaria

NCT00144352Phase 4Completed

Sponsor
Centers for Disease Control and Prevention
Start
Sep 2002
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of sulfadoxine + pyrimethamine in Plasmodium falciparum malaria, sponsored by Centers for Disease Control and Prevention. Started Sep 2002; status: completed.

02

Drugs

sulfadoxine + pyrimethamine
03

Conditions

Plasmodium falciparum malaria

Beyond the preview

Go deeper on NCT00144352.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00144352.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call